Prestige Consumer Healthcare Inc., often referred to as Prestige Brands, is a leading player in the consumer healthcare industry, headquartered in Great Britain. Founded in 1999, the company has established a strong presence in North America and other key markets, focusing on over-the-counter healthcare products. Specialising in a diverse range of categories, Prestige Brands offers unique solutions in pain relief, cold and allergy, and personal care. Their portfolio includes well-known brands that resonate with consumers, setting them apart in a competitive landscape. With a commitment to quality and innovation, Prestige Consumer Healthcare has achieved significant milestones, solidifying its market position as a trusted provider of effective healthcare solutions. The company continues to expand its reach, driven by a dedication to enhancing consumer well-being.
How does Prestige Consumer Healthcare Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Prestige Consumer Healthcare Inc's score of 31 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Prestige Consumer Healthcare Inc. reported total carbon emissions of approximately 149,927,270 kg CO2e. This figure includes 1,438,380 kg CO2e from Scope 1 emissions, 7,141,310 kg CO2e from Scope 2 emissions, and a significant 141,347,580 kg CO2e from Scope 3 emissions. This represents a notable increase from 2021, when total emissions were about 107,165,000 kg CO2e, with Scope 1 at 1,304,000 kg CO2e, Scope 2 at 5,530,000 kg CO2e, and Scope 3 at 100,330,000 kg CO2e. Despite the increase in emissions, Prestige Consumer Healthcare Inc. has not set specific reduction targets or climate pledges, indicating a potential area for improvement in their sustainability strategy. The company does not inherit emissions data from any parent organization, and all reported figures are directly from Prestige Consumer Healthcare Inc. As the company continues to operate in the consumer healthcare sector, it faces increasing pressure to enhance its climate commitments and reduce its carbon footprint, particularly in Scope 3 emissions, which constitute the majority of its total emissions.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2024 | |
|---|---|---|
| Scope 1 | 1,304,000 | 0,000,000 |
| Scope 2 | 5,530,000 | 0,000,000 |
| Scope 3 | 100,330,000 | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Prestige Consumer Healthcare Inc has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

